Warts Clinical Trials

15 recruitingLast updated: May 21, 2026

There are 15 actively recruiting warts clinical trials across 6 countries. Studies span Not Applicable, Phase 3, Phase 2, Phase 4, Phase 1. Top locations include Shenyang, Liaoning, China, San Antonio, Texas, United States, Bethesda, Maryland, United States. Updated daily from ClinicalTrials.gov.


Warts Trials at a Glance

15 actively recruiting trials for warts are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Shenyang, San Antonio, and Bethesda. Lead sponsors running warts studies include First Hospital of China Medical University, National Institute of Allergy and Infectious Diseases (NIAID), and Verrica Pharmaceuticals Inc..

Browse warts trials by phase

About Warts Clinical Trials

Looking for clinical trials for Warts? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Warts trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Warts clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Cryptococcal MeningitisWartsIdiopathic CD4+ Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID)950 enrolled1 locationNCT00867269
Recruiting
Phase 1Phase 2

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

NeutropeniaInfectionsWarts+2 more
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT00967785
Recruiting
Phase 3

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Human Papilloma Virus (HPV)WartsCommon Warts+1 more
Verrica Pharmaceuticals Inc.600 enrolled4 locationsNCT07457918
Recruiting
Not Applicable

Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts

Refactory Warts
First Hospital of China Medical University80 enrolled2 locationsNCT07565350
Recruiting
Phase 4

Comparison of Efficacy of Topical Adaplene Gel Versus Crythotherapy in Recurrent Plantar Warts

Viral Warts
Khyber Teaching Hospital98 enrolled1 locationNCT07016360
Recruiting
Phase 4

Tirbanibulin for Pediatric Warts

Warts Hand
The Skin Center Dermatology Group10 enrolled1 locationNCT06791525
Recruiting
Not Applicable

Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts

Warts
First Hospital of China Medical University210 enrolled1 locationNCT07534865
Recruiting
Phase 4

Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir

Common WartFlat WartPlantar Wart+5 more
Riphah International University40 enrolled2 locationsNCT07448844
Recruiting
Phase 3

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

Human Papilloma Virus (HPV)WartsCommon Warts+1 more
Verrica Pharmaceuticals Inc.300 enrolled6 locationsNCT07246590
Recruiting
Not Applicable

Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart

Common Warts
Mazandaran University of Medical Sciences60 enrolled1 locationNCT06737406
Recruiting
Not Applicable

Multicenter Real-World Study of Hyperthermia in Warts of Special Population

Warts
First Hospital of China Medical University400 enrolled1 locationNCT06827938
Recruiting
Phase 2

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

Human Papilloma VirusWarts
Zagazig University162 enrolled1 locationNCT05291845
Recruiting
Not Applicable

Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts

Warts
First Hospital of China Medical University300 enrolled2 locationsNCT06812065
Recruiting
Phase 3

Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts

Palmar or Plantar Warts
Assistance Publique - Hôpitaux de Paris146 enrolled1 locationNCT04814446
Recruiting
Phase 2Phase 3

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Warts
Western Institute for Veterans Research120 enrolled2 locationsNCT05625633